In Vitro & In Vivo Diagnostic Substances · CA · CIK 1642380
Develops molecular diagnostic test kits for in-house use, initially for transplanted organ rejection testing
Comparable business profile · signals at a glance
In the 90 days to Feb 10, 2026: 1 insider bought $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Bradsher Neal CTenPercentOwner | Buy | 521,739 | $5.75 | $3.0M |
| Feb 10, 2026 | Bradsher Neal CTenPercentOwner | Buy | 0 | $0.00 | $0 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.